Alerts will be sent to your verified email
Verify EmailORCHPHARMA
Orchid Pharma
|
Gufic Biosciences
|
Guj. Themis Biosyn
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-4.13 % | 25.05 % | 41.95 % |
5yr average Equity Multiplier
|
1.73 | 2.22 | 1.37 |
5yr Average Asset Turnover Ratio
|
0.45 | 1.05 | 0.89 |
5yr Avg Net Profit Margin
|
-7.02 % | 10.9 % | 34.6 % |
Price to Book
|
3.11 | 6.41 | 16.31 |
P/E
|
39.55 | 55.31 | 90.85 |
5yr Avg Cash Conversion Cycle
|
49.11 Days | 26.94 Days | -31.8 Days |
Inventory Days
|
112.59 Days | 66.86 Days | 23.52 Days |
Days Receivable
|
91.49 Days | 128.09 Days | 48.29 Days |
Days Payable
|
201.52 Days | 163.91 Days | 135.34 Days |
5yr Average Interest Coverage Ratio
|
-0.51 | 13.1 | 187.52 |
5yr Avg ROCE
|
0.51 % | 27.25 % | 54.74 % |
5yr Avg Operating Profit Margin
|
10.69 % | 18.45 % | 45.69 % |
5 yr average Debt to Equity
|
0.49 | 0.51 | 0.05 |
5yr CAGR Net Profit
|
n/a | 14.26 % | 20.11 % |
5yr Average Return on Assets
|
-1.77 % | 11.52 % | 30.29 % |
Shareholdings
|
|||
Promoter Holding
|
69.84 % | 72.52 % | 70.86 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-20.12 % | -2.48 % | -4.13 % |
Change in Mutual Fund Holding (3 Yrs)
|
16.13 % | 2.35 % | 1.14 % |
Orchid Pharma
|
Gufic Biosciences
|
Guj. Themis Biosyn
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Asset Break-Up - Geography Wise
|
Asset Break-Up - Geography Wise
|
-
|
-
|